Nanogen Hopes to Raise $20M in Convertible Debt to Fatten Working Capital | GenomeWeb
NEW YORK (GenomeWeb News) — Nanogen today said it hopes to raise $20 million in a registered offering unsecured senior convertible notes and warrants to institutional investors.
 
The transaction, which is expected to fund today, will be overseen by Seven Hills Partners. The investors were not disclosed, though in a statement Nanogen CEO Howard Birndorf called them “solid” and “familiar with both our market place and our long term prospects.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.